Leqembi

Stock Market

Biogen Expects Alzheimer’s Drug Leqembi To Face A Key 2023 Headwind

February 15, 2023
Photo of Biogen Expects Alzheimer’s Drug Leqembi To Face A Key 2023 Headwind

[ad_1] Biogen (BIIB) stock was hamstrung Wednesday on a mixed 2023 outlook that assumes expenses for new Alzheimer’s treatment will…

Read More »
Back to top button
Close